Related Experiment Video
Updated: Oct 11, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
Function of N6-Methyladenosine Modification in Tumors
Nan Zhang1, Yuxin Zuo1, Yu Peng1
1Department of Physiology, Institute of Neuroscience Research, Hengyang Key Laboratory of Neurodegeneration and Cognitive Impairment, Hengyang Medical School, University of South China, 28 West Changsheng Road, Hengyang 421001, Hunan, China.
Abstract:
N6-Methyladenosine (m6A) modification is a dynamic and reversible methylation modification at the N6-position of adenosine. As one of the most prevalent posttranscriptional methylation modifications of RNA, m6A modification participates in several mRNA processes, including nuclear export, splicing, translation, and degradation. Some proteins, such as METTL3, METTL14, WTAP, ALKBH5, FTO, and YTHDF1/2/3, are involved in methylation. These proteins are subdivided into writers (METTL3, METTL14, WTAP), erasers (ALKBH5, FTO), and readers (YTHDF1/2/3) according to their functions in m6A modification. Several studies have shown that abnormal m6A modification occurs in tumors, including colorectal cancer, liver cancer, breast cancer, nasopharyngeal carcinoma, and gastric cancer. The proteins for m6A modification are involved in tumor proliferation, angiogenesis, metastasis, immunity, and other processes. Herein, the roles of m6A modification in cancer are discussed, which will improve the understanding of tumorigenesis, as well as the diagnosis, treatment, and prognosis of tumors.
Insights
N6-Methyladenosine (m6A) modification is a key RNA process influencing cancer. Understanding m6A writers, erasers, and readers offers insights into tumor development and potential treatments.
Area of Science:
- Molecular Biology
- Epigenetics
- Oncology
Background:
- N6-Methyladenosine (m6A) is a prevalent RNA modification impacting mRNA metabolism.
- m6A modification involves specific proteins categorized as writers, erasers, and readers.
- Aberrant m6A patterns are observed in various cancers.
Purpose of the Study:
- To review the roles of m6A modification in cancer.
- To elucidate the involvement of m6A-related proteins in tumorigenesis.
- To highlight the potential of m6A in cancer diagnosis, treatment, and prognosis.
Main Methods:
- Literature review of studies on m6A modification in cancer.
- Analysis of the functions of m6A 'writers' (METTL3, METTL14, WTAP), 'erasers' (ALKBH5, FTO), and 'readers' (YTHDF1/2/3).
- Examination of m6A's influence on tumor proliferation, angiogenesis, metastasis, and immunity.
Main Results:
- m6A modification is implicated in fundamental mRNA processing.
- Dysregulated m6A pathways are linked to tumorigenesis across multiple cancer types.
- m6A-associated proteins play critical roles in cancer progression.
Conclusions:
- m6A modification is a significant factor in cancer biology.
- Targeting m6A pathways may offer novel therapeutic strategies.
- Further research into m6A is crucial for improving cancer care.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
MicroRNAs
RNA Editing
Pre-mRNA Processing: Modification of pre-mRNA Ends
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
RNA Stability

